omeprazole has been researched along with tenatoprazole in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 10 (50.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clardy, J; Derbyshire, ER; Mota, MM; Prudêncio, M | 1 |
| Bi, Y; Kuberan, B; Might, M; Vankayalapati, H | 1 |
| Beghyn, T; Bosc, D; Charton, J; Deprez, B; Deprez-Poulain, R; Guillaume, V; Herledan, A; Hermant, P; Landry, V; Leroux, F; Liang, W; Pottiez, V; Sheng, L; Tang, WJ; Urata, S; Warenghem, S | 1 |
| Cortés-Benítez, F; Palacios-Espinosa, JF; Pérez-Villanueva, J; Rodríguez-Villar, K; Soria-Arteche, O; Yépez-Mulia, L | 1 |
| Araki, T; Kakinoki, B; Morinaka, Y; Takeuchi, Y; Uchiyama, K; Wakatsuki, D | 2 |
| Chikamatsu, N; Kakinoki, B; Morinaka, Y; Ono, C; Uchiyama, K; Wakatsuki, D; Yamazaki, N | 1 |
| Nakamura, T | 1 |
| Domagala, F; Ficheux, H; Homerin, M; Sachs, G; Shin, JM | 1 |
| Barré, J; Domagala, F; Ficheux, H; Houin, G | 1 |
| Cohen, P; Domagala, F; Ficheux, H; Fiorentini, P; Homerin, M; Taccoen, A; Thomson, AB | 1 |
| Li, F; Liu, P; Lu, X; Qin, F; Sun, B | 1 |
| Bhyrapuneni, G; Kandikere, V; Mudigonda, K; Nirogi, R | 1 |
| Bi, Y; Guan, J; Li, F; Shi, S; Yang, J | 1 |
| Guan, J; Li, F; Li, J; Li, X; Yang, J | 1 |
| Bhusari, V; Dhaneshwar, S; Kulkarni, M; Mahadik, M | 1 |
| Hofmann, U; Nies, AT; Resch, C; Rius, M; Schaeffeler, E; Schwab, M | 1 |
| Arnaud, B; Arnoult, C; Escoffier, J; Hograindleur, JP; Kaba, M; Le Blévec, E; Martinez, G; Nef, S; Ray, PF; Stévant, I | 1 |
| Cheng, T; Gu, ZH; Han, TY; Liu, BF; Pan, P; Yu, H | 1 |
2 review(s) available for omeprazole and tenatoprazole
| Article | Year |
|---|---|
[Proton pump inhibitors: Tenatoprazole (TU-199)].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Clinical Trials as Topic; Depression, Chemical; Gastric Acid; Humans; Imidazoles; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Pyridines | 2002 |
Tenatoprazole. Benatoprazole, TU 199.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Clinical Trials as Topic; Humans; Imidazoles; Omeprazole; Peptic Ulcer; Pyridines | 2002 |
2 trial(s) available for omeprazole and tenatoprazole
| Article | Year |
|---|---|
Pharmacokinetics of tenatoprazole, a newly synthesized proton pump inhibitor, in healthy male Caucasian volunteers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cytochrome P-450 CYP2C19; Enzyme Inhibitors; Genotype; Humans; Imidazoles; Male; Mixed Function Oxygenases; Omeprazole; Proton Pump Inhibitors; Pyridines; Reverse Transcriptase Polymerase Chain Reaction | 2006 |
Comparison of the effects of fasting morning, fasting evening and fed bedtime administration of tenatoprazole on intragastric pH in healthy volunteers: a randomized three-way crossover study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Analysis of Variance; Anti-Ulcer Agents; Circadian Rhythm; Cross-Over Studies; Drug Administration Schedule; Eating; Fasting; Gastric Acidity Determination; Gastric Juice; Humans; Hydrogen-Ion Concentration; Imidazoles; Male; Omeprazole; Pyridines; Statistics, Nonparametric | 2006 |
16 other study(ies) available for omeprazole and tenatoprazole
| Article | Year |
|---|---|
Liver-stage malaria parasites vulnerable to diverse chemical scaffolds.
Topics: Animals; Anopheles; Antimalarials; Drug Evaluation, Preclinical; Hep G2 Cells; Humans; Inhibitory Concentration 50; Insect Vectors; Life Cycle Stages; Liver; Malaria; Malaria, Falciparum; Male; Mice; Mice, Inbred C57BL; Plasmodium berghei; Plasmodium falciparum; Treatment Outcome | 2012 |
Repurposing of Proton Pump Inhibitors as first identified small molecule inhibitors of endo-β-N-acetylglucosaminidase (ENGase) for the treatment of NGLY1 deficiency, a rare genetic disease.
Topics: Dose-Response Relationship, Drug; Enzyme Inhibitors; Genetic Diseases, Inborn; Humans; Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase; Molecular Structure; Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase; Proton Pump Inhibitors; Proton Pumps; Rabeprazole; Small Molecule Libraries; Structure-Activity Relationship | 2017 |
Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening.
Topics: Azoles; Biocatalysis; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Repositioning; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Insulysin; Isoindoles; Molecular Structure; Organoselenium Compounds; Structure-Activity Relationship | 2019 |
The giardicidal activity of lobendazole, fabomotizole, tenatoprazole and ipriflavone: A ligand-based virtual screening and in vitro study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antiprotozoal Agents; Benzimidazoles; Carbamates; Humans; In Vitro Techniques; Isoflavones; Ligands | 2021 |
Effects of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion and gastroduodenal ulcers in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Drug Evaluation, Preclinical; Gastric Acid; Imidazoles; Male; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley | 1999 |
The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Analgesics, Non-Narcotic; Animals; Anti-Ulcer Agents; Carbachol; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gastric Acid; Gastric Fistula; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Histamine; Hydrogen-Ion Concentration; Imidazoles; Lansoprazole; Male; Microsomes; Omeprazole; Proton Pump Inhibitors; Pyridines; Stomach; Tetragastrin; Time Factors | 1999 |
General pharmacological properties of the new proton pump inhibitor (+/-)-5-methoxy-2-[[(4-methoxy-3,5-dimethylpyrid-2-yl)methyl]sulf inyl]- 1H-imidazo[4,5-b]pyridine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Dogs; Guinea Pigs; Ileum; Imidazoles; In Vitro Techniques; Male; Mice; Motor Activity; Omeprazole; Proton Pump Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Seizures | 1999 |
Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Binding Sites; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gastric Acid; Gastric Mucosa; Glutathione; H(+)-K(+)-Exchanging ATPase; Half-Life; Imidazoles; In Vitro Techniques; Male; Omeprazole; Proton Pump Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Stomach; Swine | 2006 |
HPLC determination and pharmacokinetic study of tenatoprazole in dog plasma after oral administration of enteric-coated capsule.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Animals; Calibration; Capsules; Chromatography, High Pressure Liquid; Dogs; Drug Stability; Imidazoles; Molecular Structure; Omeprazole; Pyridines; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2007 |
Quantification of tenatoprazole in rat plasma by HPLC: validation and its application to pharmacokinetic studies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Chromatography, High Pressure Liquid; Imidazoles; Male; Omeprazole; Proton Pump Inhibitors; Pyridines; Rats; Rats, Wistar; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Time Factors | 2007 |
[Chiral separation of tenatoprazole enantiomers using high performance liquid chromatography on vacomycin-bonded chiral stationary phase].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Imidazoles; Molecular Structure; Omeprazole; Reproducibility of Results; Stereoisomerism | 2007 |
Determination of tenatoprazole enantiomers and their enantioselective pharmacokinetics in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Animals; Chromatography, High Pressure Liquid; Imidazoles; Linear Models; Male; Omeprazole; Rats; Rats, Wistar; Sensitivity and Specificity; Stereoisomerism; Substrate Specificity; Time Factors | 2009 |
LC-UV and LC-MS evaluation of stress degradation behaviour of tenatoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chemistry, Pharmaceutical; Chromatography; Chromatography, Liquid; Drug Stability; Hot Temperature; Hydrogen Peroxide; Hydrolysis; Imidazoles; Mass Spectrometry; Models, Chemical; Omeprazole; Oxygen; Photochemistry; Reproducibility of Results; Spectrophotometry, Ultraviolet; Temperature | 2009 |
Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Biological Transport; Cell Line; Humans; Imidazoles; Immunoblotting; Inhibitory Concentration 50; Lansoprazole; Metformin; Omeprazole; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2; Protein Binding; Proton Pump Inhibitors; Rabeprazole | 2011 |
Pantoprazole, a proton-pump inhibitor, impairs human sperm motility and capacitation in vitro.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Fertilization; Humans; Lansoprazole; Male; Membrane Potentials; Middle Aged; Omeprazole; Pantoprazole; Phosphorylation; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Semen Analysis; Sperm Capacitation; Sperm Maturation; Sperm Motility; Spermatozoa; Young Adult | 2020 |
Effectiveness and safety of proton pump inhibitors for treating acute pancreatitis: A protocol for systematic review and meta analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Humans; Meta-Analysis as Topic; Omeprazole; Pancreatitis; Pantoprazole; Proton Pump Inhibitors; Research Design; Systematic Review as Topic | 2021 |